Financial
-
Johnson & Johnson Reports 2013 First-Quarter Results
Sales of $17.5 Billion Increased 8.5% Versus 2012 First Quarter; First-Quarter EPS was $1.22 Excluding Special Items, 2013 First-Quarter EPS of $1.44 Increased 5.1%* -
-
-
-
Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life-Science Start-Ups
At one year anniversary, 18 diverse life-science start-up companies operating from Janssen Labs -
-
-
Johnson & Johnson Reports 2012 Third-Quarter Results
Sales of $17.1 Billion increased 6.5% Versus 2011 Third Quarter; Third-Quarter EPS was $1.05Excluding Special Items, 2012 Third-Quarter EPS of $1.25 increased 0.8%* -